Let's Talk

Our Services

Primary Cells
  • Identification and characterization of cancer-specific mutations.
  • Detection of large chromosomal rearrangements in cancer cells.
  • Conduction of comprehensive genomic profiling for personalized medicine.
Biomarker and Protein Analysis
  • Evaluation of expression levels of cancer-specific biomarkers.
  • Validation of potential therapeutic targets through protein analysis.
  • Conduction of multiplex assays for simultaneous detection of multiple biomarkers.
Immune Profiling and Functional Assays
  • Profiling of the immune cell populations in the tumor microenvironment.
  • Assessment of T-cell receptor diversity and clonality.
  • Evaluation of the functional activity of immune cells, such as cytotoxicity and cytokine production.
Cell Viability, Proliferation, and Apoptosis
  • Assessment of cell proliferation rates.
  • Evaluation of apoptosis induction levels and measurement of cellular viability.
  • Monitoring the metabolic activity as an indicator of cell health.
Invasiveness and Metastasis Testing
  • Evaluation of the invasive potential of cancer cells.
  • Assessment of the effects of drugs on cell migration and invasion.
Compound Screening and Drug Discovery
  • High-throughput screening for potential anticancer compounds for cytotoxicity.
  • Assessment of cell proliferation rates in response to treatments.
  • Identification of lead compounds and validation through secondary assays and mechanistic studies.
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
Contact Us
28047 Dorothy Drive, #204,
Agoura Hills, CA 91301, USA
Call: +1 442-224-3375
E-mail: Info@drlus.com
Linkedin
Useful Links
©2024 DRL US. . All Rights Reserved.
Designed & Developed by Echoru LLC® in California